DIANEAL PD-4 PERITONEAL DIALYSIS SOLUTION 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

dianeal pd-4 peritoneal dialysis solution

baxter healthcare pty ltd - glucose monohydrate, quantity: 15 g/l; sodium chloride, quantity: 5.38 g/l; sodium lactate, quantity: 4.48 g/l; calcium chloride dihydrate, quantity: 183 mg/l; magnesium chloride hexahydrate, quantity: 50.8 mg/l - solution, irrigation - excipient ingredients: hydrochloric acid; water for injections - dianeal low calcium peritoneal dialysis solution is indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis or intermittent peritoneal dialysis and/or automated peritoneal dialysis and can also be used for acute renal failure.

DIANEAL PD-2 Peritoneal Dialysis with 4.25% w/v Glucose Solution 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

dianeal pd-2 peritoneal dialysis with 4.25% w/v glucose solution

baxter healthcare pty ltd - glucose monohydrate, quantity: 4.25 g/l; sodium chloride, quantity: 5.38 g/l; sodium lactate, quantity: 4.48 g/l; calcium chloride dihydrate, quantity: 257 mg/l; magnesium chloride hexahydrate, quantity: 50.8 mg/l - solution, irrigation - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - dianeal low calcium peritoneal dialysis solution is indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis or intermittent peritoneal dialysis and/or automated peritoneal dialysis and can also be used for acute renal failure.

DIANEAL PD-2 Peritoneal Dialysis with 2.5% w/v Glucose Solution 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

dianeal pd-2 peritoneal dialysis with 2.5% w/v glucose solution

baxter healthcare pty ltd - glucose monohydrate, quantity: 25 g/l; sodium chloride, quantity: 5.38 g/l; sodium lactate, quantity: 4.48 g/l; calcium chloride dihydrate, quantity: 257 mg/l; magnesium chloride hexahydrate, quantity: 50.8 mg/l - solution, irrigation - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code),dianeal low calcium peritoneal dialysis solution is indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis or intermittent peritoneal dialysis and/or automated peritoneal dialysis and can also be used for acute renal failure.

DIANEAL PD-2 Peritoneal Dialysis with 1.5% w/v Glucose Solution 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

dianeal pd-2 peritoneal dialysis with 1.5% w/v glucose solution

baxter healthcare pty ltd - glucose monohydrate, quantity: 15 g/l; sodium chloride, quantity: 5.38 g/l; sodium lactate, quantity: 4.48 g/l; calcium chloride dihydrate, quantity: 257 mg/l; magnesium chloride hexahydrate, quantity: 50.8 mg/l - solution, irrigation - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code),dianeal low calcium peritoneal dialysis solution is indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis or intermittent peritoneal dialysis and/or automated peritoneal dialysis and can also be used for acute renal failure.

DIANEAL PD-2 Peritoneal Dialysis with 0.55% w/v Glucose Solution 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

dianeal pd-2 peritoneal dialysis with 0.55% w/v glucose solution

baxter healthcare pty ltd - glucose monohydrate, quantity: 5.5 g/l; sodium chloride, quantity: 5.38 g/l; sodium lactate, quantity: 4.48 g/l; calcium chloride dihydrate, quantity: 257 mg/l; magnesium chloride hexahydrate, quantity: 50.8 mg/l - solution, irrigation - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - dianeal low calcium peritoneal dialysis solution is indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis or intermittent peritoneal dialysis and/or automated peritoneal dialysis and can also be used for acute renal failure.

VIMPAT lacosamide 10 mg/mL oral solution bottle 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

vimpat lacosamide 10 mg/ml oral solution bottle

ucb australia pty ltd t/a ucb pharma division of ucb australia - lacosamide, quantity: 10 mg - solution - excipient ingredients: glycerol; sodium chloride; carmellose sodium; sorbitol solution (70 per cent) (crystallising); macrogol 4000; citric acid; acesulfame potassium; sodium methyl hydroxybenzoate; purified water; flavour - vimpat (lacosamide) tablets and oral solution are indicated as:,? monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.,? add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.,? add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with idiopathic generalised epilepsy aged 4 years and older.

HARTMANN'S SOLUTION COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP 爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

hartmann's solution compound sodium lactate intravenous infusion bp

maco pharma (uk) ltd - sodium chloride ; calcium chloride dihydrate ; potassium chloride ; sodium lactate solution 60% - solution for infusion - 6/0.27/0.4 grams - electrolytes

HARTMANN'S SOLUTION COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP 爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

hartmann's solution compound sodium lactate intravenous infusion bp

maco pharma (uk) ltd - sodium chloride ; calcium chloride dihydrate ; potassium chloride ; sodium lactate solution 60% - solution for infusion - grams - electrolytes

BAXTER CARDIOPLEGIA SOLUTION A, 1000mL solution bag 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

baxter cardioplegia solution a, 1000ml solution bag

baxter healthcare pty ltd - sodium chloride, quantity: 6.43 g/l; potassium chloride, quantity: 1.19 g/l; magnesium chloride hexahydrate, quantity: 3.25 g/l; calcium chloride dihydrate, quantity: 0.176 g/l - solution - excipient ingredients: water for injections; hydrochloric acid - other conditions: the ph of the solution must be adjusted to 7.4 to 7. 8 with 10ml of sodium bicarbonate 8.4% w/v injection bp (not supplied) before use. indications: following ph adjustment with 10ml of sodium bicarbonate 8.4% w/v injection bp, cardioplegia "a" solution is used in combination with ischaemia and hypothermia to induce cardiac arrest during open heart surgery and to preserve the myocardium during asystole.

BUVIDAL WEEKLY buprenorphine 32 mg/0.64 mL modified release solution for injection 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

buvidal weekly buprenorphine 32 mg/0.64 ml modified release solution for injection

camurus pty ltd - buprenorphine, quantity: 32 mg - injection, solution - excipient ingredients: ethanol absolute; phosphatidyl choline; glyceryl dioleate; nitrogen - buvidal weekly is indicated for initiation and maintenance treatment of opioid dependence, with or without prior stabilisation on sublingual buprenorphine or buprenorphine/naloxone, within a framework of medical, social and psychological support.